Universität des Saarlandes
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1948-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.uni-saarland.de
Inspiratory Muscle Training (IMT) in Athletes
Not Applicable
Completed
- Conditions
- Running Endurance
- Interventions
- Behavioral: Respiratory muscle trainingBehavioral: Sham training
- First Posted Date
- 2009-08-31
- Last Posted Date
- 2011-01-05
- Lead Sponsor
- Universität des Saarlandes
- Target Recruit Count
- 40
- Registration Number
- NCT00968448
- Locations
- 🇩🇪
Universität des Saarlands, Saarbrücken, Saarland, Germany
Effect of Elite Soccer Training on Routine Laboratory Parameters
Completed
- Conditions
- Stress
- First Posted Date
- 2009-07-27
- Last Posted Date
- 2009-07-27
- Lead Sponsor
- Universität des Saarlandes
- Target Recruit Count
- 467
- Registration Number
- NCT00946855
- Locations
- 🇩🇪
Institute of Sports and Preventive Medicine, University of Saarland, Campus, Bldg. B 8-2,, Saarbrücken, Saarland, Germany
Training Study to Evaluate the Benefit of Exercise for Patients With Chronic Heart Failure
Not Applicable
Completed
- Conditions
- Dilated CardiomyopathyChronic Heart Failure
- Interventions
- Behavioral: Endurance training
- First Posted Date
- 2009-07-08
- Last Posted Date
- 2009-09-18
- Lead Sponsor
- Universität des Saarlandes
- Target Recruit Count
- 66
- Registration Number
- NCT00934609
- Locations
- 🇩🇪
Institute of Sports- and Preventive Medicine, Saarland University, Saarbrücken, Saarland, Germany
Predictors of Individual Training Effectiveness in Preventive Exercise
Not Applicable
Completed
- Conditions
- Primary Prevention
- Interventions
- Behavioral: Endurance training
- First Posted Date
- 2009-07-08
- Last Posted Date
- 2011-08-26
- Lead Sponsor
- Universität des Saarlandes
- Target Recruit Count
- 15
- Registration Number
- NCT00934206
- Locations
- 🇩🇪
Institute of Sports- and Preventive Medicine, Saarland University, Saarbrücken, Saarland, Germany
Pegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin Lymphoma
Phase 2
Completed
- Conditions
- Lymphoma
- Interventions
- Biological: pegfilgrastimBiological: rituximabDrug: cyclophosphamideDrug: doxorubicin hydrochlorideDrug: prednisoneDrug: vincristine sulfate
- First Posted Date
- 2008-08-01
- Last Posted Date
- 2021-07-07
- Lead Sponsor
- Universität des Saarlandes
- Target Recruit Count
- 109
- Registration Number
- NCT00726700
© Copyright 2025. All Rights Reserved by MedPath